Expert Opinion on Pharmacotherapy logo Informa Healthcare logo

Publisher: Informa Healthcare

More about this publication?
Related content
Volume 14, Number 1, January 2013

< previous issue | all issues | next issue >

Articles

Related articles
pp. i-i(1)

Editorial

Original Research

Absence of QTc prolongation with betrixaban: a randomized, double-blind, placebo- and positive-controlled thorough ECG study
pp. 5-13(9)
Authors: Morganroth, Joel; Gretler, Daniel D; Hollenbach, Stanley J; Lambing, Joseph L; Sinha, Uma

Safety and efficacy of rotigotine transdermal patch in patients with restless legs syndrome: a post-hoc analysis of patients taking 1 - 3 mg/24 h for up to 5 years
pp. 15-25(11)
Authors: Dohin, Elisabeth; Högl, Birgit; Ferini-Strambi, Luigi; Schollmayer, Erwin; Fichtner, Andreas; Bauer, Lars; García-Borreguero, Diego

Second-line treatments for the management of advanced renal cell carcinoma: systematic review and meta-analysis
pp. 27-39(13)
Authors: Larkin, James; Paine, Abby; Tumur, Indra; Cappelleri, Joseph C; Healey, Paul J; Foley, Grace; Mitchell, Stephen; Kroes, Michel; Chen, Connie

Reviews

Functional constipation in childhood: current pharmacotherapy and future perspectives
pp. 41-51(11)
Authors: Hoekman, Daniël Robin; Benninga, Marc Alexander

Leishmaniasis: an update of current pharmacotherapy
pp. 53-63(11)
Authors: Sundar, Shyam; Chakravarty, Jaya

Pharmacotherapy for pneumococcal infections: an update
pp. 65-77(13)
Authors: Esposito, Susanna; Principi, Nicola

The evolving pharmacotherapy of pulmonary fibrosis
pp. 79-89(11)
Authors: Lota, Harpreet K; Wells, Athol U

Drug Evaluations

Abiraterone acetate for the treatment of prostate cancer
pp. 91-96(6)
Authors: Ryan, Charles J; Cheng, Michael L

Tacrolimus in transplant rejection
pp. 115-122(8)
Author: Rath, Thomas

Cladribine tablets for the treatment of relapsing-remitting multiple sclerosis
pp. 123-136(14)
Authors: Comi, Giancarlo; Hartung, Hans-Peter; Kurukulasuriya, Nuwan C; Greenberg, Steven J; Scaramozza, Matthew

An update on lisdexamfetamine dimesylate for the treatment of attention deficit hyperactivity disorder
pp. 137-145(9)
Authors: Wigal, Sharon B; Raja, Pooja; Shukla, Ankita

Appendix

Erratum
pp. 147-147(1)

Erratum
pp. 149-149(1)

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page